MNKD MannKind Corp

$5.38

*Only the 1D chart reflects 15-min delayed quotes during market hours. Other timeframes update after market close.

Reporting for fiscal period ending —
Expected on —
Report Time: Unknown Release Time
The Whisper Number
—
Consensus Estimate: —
Revenue Estimate: —

Latest Earnings Insight

Updated On 9/16/2025

About MannKind Corp

MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutics for endocrine and orphan lung diseases in the United States. The company is headquartered in Westlake Village, California.

Website: https://www.mannkindcorp.com

Sector
LIFE SCIENCES
Industry
PHARMACEUTICAL PREPARATIONS
Exchange
NASDAQ
Country
USA
Currency
USD
Fiscal Year End
December
CIK
899460
Address
30930 RUSSELL RANCH ROAD, SUITE 300, WESTLAKE VILLAGE, CA, US
Valuation
Market Cap
$1.38B
P/E Ratio
45.40
PEG Ratio
-0.23
Price to Book
0.00
Performance
EPS
$0.10
Dividend Yield
—
Profit Margin
9.66%
ROE
0.00%
Technicals
50D MA
$5.16
200D MA
$5.95
52W High
$7.63
52W Low
$4.06
Fundamentals
Shares Outstanding
304M
Target Price
$10.29
Beta
1.21

MNKD EPS Estimates vs Actual

● Estimated
● Actual

MNKD News & Sentiment

Sep 15, 2025 • Benzinga SOMEWHAT-BULLISH
$HAREHOLDER ALERT: The M&A Class Action Firm Is Investigating the Merger - GTLS, SCPH, VTLE, and VRNT
NEW YORK, Sept. 15, 2025 ( GLOBE NEWSWIRE ) -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC ( the "M&A Class Action Firm" ) , has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in the 2024 ISS Securities Class Action Services Report.
Sep 10, 2025 • Zacks Commentary SOMEWHAT-BULLISH
Why Is Denali Therapeutics ( DNLI ) Up 16.2% Since Last Earnings Report?
Denali Therapeutics (DNLI) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Sep 02, 2025 • Benzinga SOMEWHAT-BULLISH
Air Lease, Ionis Pharmaceuticals, Arrowhead Pharmaceuticals And Other Big Stocks Moving Higher On Tuesday - Apollo Asset Management ( NYSE:APO ) , Air Lease ( NYSE:AL )
U.S. stocks were lower, with the Dow Jones index falling over 250 points on Tuesday. Shares of Air Lease Corporation AL rose sharply during Tuesday's session after the aircraft lessor said it will be acquired by a newly formed Dublin-based holding company backed by Sumitomo Corp.
Aug 28, 2025 • Benzinga SOMEWHAT-BULLISH
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates IMXI, HBI, VTLE, SCPH on Behalf of Shareholders - International Money ( NASDAQ:IMXI ) , Hanesbrands ( NYSE:HBI )
NEW YORK, Aug. 28, 2025 ( GLOBE NEWSWIRE ) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: International Money Express, Inc.
Aug 28, 2025 • Benzinga SOMEWHAT-BULLISH
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: scPharmaceuticals Inc. ( Nasdaq - SCPH ) , Vital Energy, Inc. ( NYSE - VTLE ) , International Money Express, Inc. ( Nasdaq - IMXI ) , HanesBrands Financial Corp. ( NYSE - HBI )
BALA CYNWYD, Pa., Aug. 28, 2025 ( GLOBE NEWSWIRE ) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky ( jbrodsky@brodskysmith.com ) or Marc Ackerman ( mackerman@brodskysmith.com ) at 855-576-4847.
Aug 27, 2025 • Benzinga SOMEWHAT-BULLISH
MannKind Announces Expansion of United Therapeutics Collaboration for Second Inhaled Therapy - MannKind ( NASDAQ:MNKD ) , United Therapeutics ( NASDAQ:UTHR )
DANBURY, Conn. and BOSTON, Aug. 27, 2025 ( GLOBE NEWSWIRE ) -- MannKind Corporation MNKD today announced that United Therapeutics Corporation UTHR has exercised its option-granted under the companies' 2018 license and collaboration agreement-to develop a second dry powder inhalation therapy.
Sentiment Snapshot

Average Sentiment Score:

0.196
50 articles with scored sentiment

Overall Sentiment:

Bullish

MNKD Reported Earnings

Feb 25, 2025
Dec 31, 2024 (Pre market)
-0.0 Surprise
  • Reported EPS: $0.03
  • Estimate: $0.03
  • Whisper: —
  • Surprise %: -15.0%
Nov 07, 2024
Sep 30, 2024 (Post market)
0.02 Surprise
  • Reported EPS: $0.05
  • Estimate: $0.03
  • Whisper: —
  • Surprise %: 66.7%
Aug 07, 2024
Jun 30, 2024 (Pre market)
-0.02 Surprise
  • Reported EPS: $-0.01
  • Estimate: $0.01
  • Whisper: —
  • Surprise %: -200.0%
May 08, 2024
Mar 31, 2024 (Post market)
0.01 Surprise
  • Reported EPS: $0.04
  • Estimate: $0.03
  • Whisper: —
  • Surprise %: 33.3%
Feb 27, 2024
Dec 31, 2023 (Post market)
-0.01 Surprise
  • Reported EPS: $0.00
  • Estimate: $0.01
  • Whisper: —
  • Surprise %: -57.0%
Nov 07, 2023
Sep 30, 2023 (Post market)
0.03 Surprise
  • Reported EPS: $0.01
  • Estimate: $-0.02
  • Whisper: —
  • Surprise %: 150.0%
Aug 07, 2023
Jun 30, 2023 (Post market)
0.02 Surprise
  • Reported EPS: $-0.02
  • Estimate: $-0.04
  • Whisper: —
  • Surprise %: 50.0%
May 09, 2023
Mar 31, 2023 (Post market)
0.01 Surprise
  • Reported EPS: $-0.04
  • Estimate: $-0.05
  • Whisper: —
  • Surprise %: 20.0%
Feb 22, 2023
Dec 31, 2022 (Pre market)
-0.01 Surprise
  • Reported EPS: $-0.07
  • Estimate: $-0.06
  • Whisper: —
  • Surprise %: -16.7%

Financials